Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-054880)

Filing Details

Accession Number:: 0001209191-10-054880
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-15 09:56:18
Reporting Period:: 2010-11-12

Filing Date:: 2010-11-15
Accepted Time:: 2010-11-15 09:56:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193366	El Youssef Zein	C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-12	25,029	$2.82	564,169	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.79 to $2.85, inclusive. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.